Drug intelligence / Profile preview

Tendoncel

Development stage
Phase 2
Lead developer
Celixir
Modality
Cell Therapies, Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

Tendoncel is a novel, patented, regenerative allogeneic topical gel developed for the treatment of severe tendon injuries, particularly chronic grade 3 and 4 lateral epicondylitis (tennis elbow) and rotator cuff injuries. The product incorporates a unique combination of platelet-derived growth factors—including PDGF-BB, VEGF, PDGF-AA, thrombospondin, and angiopoietin—embedded in a cellulose-derived gel matrix that controls the release of these factors to optimize their bioavailability and dosing. These growth factors are intended to facilitate healing by stimulating fibroblast proliferation and supporting tissue repair. Tendoncel is administered topically once daily for 21 days. Clinical trials have demonstrated statistically significant improvements in functional outcomes with no serious adverse events reported[1][2][3][4][5].

Brand names
Tendoncel
Other names
platelet lysate based cell therapy
02

Targets

PDGFRA (Platelet-derived growth factor receptor alpha)TEK (Tie2)VEGFR-1 (Vascular endothelial growth factor receptor 1)

Beyond the preview

Go deeper on Tendoncel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tendoncel.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call